| Literature DB >> 27423996 |
Akshaar Brahmbhatt1, Sanjay Misra2.
Abstract
Peripheral arterial disease (PAD) affects over 8 million people in the United States alone. Although great strides have been made in reducing the burden of cardiovascular disease the prevalence of PAD is expected to rise with the age of global population. PAD characterized by narrowing of arterial blood can be asymptomatic or cause limb threatening claudication. It has been classically treated with bypass, but these techniques have been supplanted by endovascular therapy. Plain old balloon angioplasty has been successful in helping revascularize lesions, but its effect has not been durable because of restenosis. This prompted the creation of several technologies aimed at reducing restenosis. These advances slowly improved outcomes and the durability of endovascular management. Among the main tools used in current endovascular practice are drug-delivery devices aimed at inhibiting the inflammatory and proliferative pathways that lead to restenosis. This article examines the current drug-delivery technologies used in the superficial femoral artery.Entities:
Keywords: PAD; SFA; drug-coated balloon; drug-eluting stent
Mesh:
Substances:
Year: 2016 PMID: 27423996 PMCID: PMC4948300 DOI: 10.1053/j.tvir.2016.04.007
Source DB: PubMed Journal: Tech Vasc Interv Radiol ISSN: 1557-9808